First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN
Martínez-Jañez, N., Ezquerra, M. Bellet, Manso Sanchez, L. M., Carrasco, F. Henao, Torres, A. Anton, Morales, S., Ortega, P. Tolosa, Gil, V. L. Obadia, Sampedro, T., Conejero, R. Andrés, Calvo-Martinez, L., Galve-Calvo, E., López, R., de la Pena, F. Ayala, Lopez-Tarruella, S., de Araguiz, B. A. Hernando Fernandez, Ruiz, L. Boronat, Cardenas, T. Martos, Chacon, J. I., Antón, F. Moreno
Published in Breast cancer research and treatment (01.07.2024)
Published in Breast cancer research and treatment (01.07.2024)
Get full text
Journal Article
Surgery of the primary tumor for de novo metastatic breast cancer: The controversy continues
López de San Vicente, B., Galve Calvo, E., Zumarraga, A., Pikab ea, F., Arango Arteaga, J.F., López Santillan, M., Figaredo, C., Sala Gonzalez, M.A., Nuño Escolastico, M., Novas Vidal, P., Legaspi, J., Martinez del Prado, P.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer
Ayala de la Peña, F., Ortiz-Muñoz, B., Quintanar-Verdúguez, T., Santotoribio, J. D., de la Cruz, S., Trapé-Pujol, J., Galve-Calvo, E., Augé-Fradera, J. M., García-Gómez, J., González-Hernández, Á.
Published in Clinical & translational oncology (01.07.2021)
Published in Clinical & translational oncology (01.07.2021)
Get full text
Journal Article
Conference Proceeding
Management of patients with metastatic breast cancer
Cruz Jurado, Josefina, Richart Aznar, Paula, García Mata, Jesus, Fernández Martínez, Roberto, Peláez Fernández, Ignacio, Sampedro Gimeno, Teresa, Galve Calvo, Elena, Murillo Jaso, Laura, Polo Marqués, Eduardo, García Palomo, Andrés
Published in Advances in therapy (01.09.2011)
Published in Advances in therapy (01.09.2011)
Get full text
Journal Article
236P Predicting Oncotype DX recurrence scores using clinicopathologic features: Tennessee University Nomogram: An external validation
Pikabea Díaz, F., Galve Calvo, E., Zumarraga, A., Figaredo Bejarano, C., Sala Gonzalez, M.A., Lopez Santillan, M., Lopez De San Vicente, B., Casado, P., Martinez del Prado, M.P.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article
EE528 Analysis of Non-Pharmacological Cost Savings Derived from the Use of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients with HER2-Positive Breast Cancer in Spain
Calleja, T., Galve-Calvo, E., Gómez Agudo, E., Llaguno, J.L., Martin Rufo, M., Arroyo, I., Lagunar Ruiz, J., Lorés, M., Monzón, M., Saura, C.
Published in Value in health (01.12.2023)
Published in Value in health (01.12.2023)
Get full text
Journal Article
387MO First results of the SOLTI-1903 HOPE's patient-centric molecular screening program in advanced breast cancer
Pascual, T., Solis, E. Segui, Olivera-Salguero, R., Cejalvo, J.M., Oliveira, M., Ortega, P. Tolosa, Losada, M.J. Vidal, Malumbres, M., Gavilá-Gregori, J., Manich, C. Saura, Simon, S. Pernas, Vila, M. Margeli, Ciruelos, E.M., Galve-Calvo, E., Galván, P., Sanfeliu Torres, E., Olmos, R., Forns, M., Fernandez Tejerina, A. Casas, Prat, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
PO-84 Incidence of venous thromboembolism and Khorana score in patients with sarcoma: a retrospective study in a single institution
Figaredo Berjano, C., Zumárraga Cuesta, A., Sala Gónzalez, M.A., López de San Vicente Hernández, A., Nuño Escolástico, M., Galve Calvo, E., Martínez del Prado, M.P.
Published in Thrombosis research (01.04.2021)
Published in Thrombosis research (01.04.2021)
Get full text
Journal Article
PO-14: Real-world data: incidence of venous thromboembolism recurrence and bleeding among cancer patients
Silva-Cardenas, D.C., Pikabea-Diaz, F., Zumarraga-Cuesta, A., Lopez-Santillan, M., Figaredo-Berjano, C., Loaiza-Jaramillo, P.L., Casado-Cuesta, P., Temiño-Frances, M., Lopez-de-San-Vicente-Hernandez, B., Novo-Sukia, E., Legaspi-Folgueira, J., Barcelo-Galindez, J.R., Sande-Sardina, L., Nuno-Escolastico, M., Abad-Villar, M.T., Sala-Gonzalez, M.A., Galve-Calvo, E., Martinez-del-Prado, M.P.
Published in Thrombosis research (01.05.2022)
Published in Thrombosis research (01.05.2022)
Get full text
Journal Article
359PSurgery of the primary tumor for de novo metastatic breast cancer: The controversy continues
López de San Vicente, B, Galve Calvo, E, Zumarraga, A, Pikab ea, F, Arango Arteaga, J F, López Santillan, M, Figaredo, C, Sala Gonzalez, M A, Nuño Escolastico, M, Novas Vidal, P, Legaspi, J, Martinez del Prado, P
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
213P Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2- advanced breast cancer in Europe
Oikonomidou, O., Galve-Calvo, E., Wöckel, A., Parikh, R., Hitchens, A., Chen, C., Gauthier, E., Li, B., Ansquer, V. Derrien, Frugier, G., Jimenez, M., Davis, K., Broughton, E.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
116P Time and motion randomised study of a subcutaneous (SC) pertuzumab and trastuzumab fixed-dose combination (PH FDC) for the treatment of HER2-positive early breast cancer (HER2 EBC): PHaTiMa
González-Santiago, S., López-Miranda, E., Escrivá-De-Romaní, S., Jiménez-Rodríguez, B., Antolín-Novoa, S., González-Cortijo, L., Fernández-Morales, L.A., Galve-Calvo, E., Martorell, A. Perello, Arroyo-Rivera, I., García-Bernáldez, C., Lagunar-Ruiz, J., Gavilá-Gregori, J.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2- advanced or metastatic breast cancer in Spain
Galve-Calvo, Elena, González-Haba, Eva, Gostkorzewicz, Joana, Martínez, Irene, Pérez-Mitru, Alejandro
Published in ClinicoEconomics and outcomes research (01.01.2018)
Published in ClinicoEconomics and outcomes research (01.01.2018)
Get full text
Journal Article
Retrospective observational study to evaluate the use of halaven plus trastuzumab for the treatment of HER2(+) metastatic breast cancer (MBC) in Spain: HALATRUST study
Echarri González, M.J., Ayala de la Peña, F., Márquez Vázquez, R., García-Saenz, J.A., Galve Calvo, E., Illarramendi Mañas, J.J., Millastre Bocos, E., Margelí Vila, M., Sánchez Rovira, P., Chacón López-Muñiz, J.I., Cerezuela Fuentes, P., Andrés Conejero, R., Cerrato Crespan, L., Marrodán Ciordia, I., Ocana Fernandez, A., Álvarez López, I., Alés Martínez, J.E., Palomar Abad, L., Orcajo Rincon, L., Rodríguez-Villanueva, J.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
275P Serological response to COVID-19 vaccine in patients with advanced breast cancer
Cuesta, P. Casado, Díaz, F. Pikabea, Galve-Calvo, E., Zumarraga, A., Penas, A. Bilbao, De San Vicente, B. López, Bejarano, C. Figaredo, Pina, I. Bernat, Legaspi, J., Galíndez, J.R. Barceló, Sardina, L. Sande, NuÑo Escolastico, M., Abad Villar, M.T., Lopez, M., Pérez Hoyos, M.T., Sala Gonzalez, M.A., Francés, M. Temiño, Jaramillo, P.L. Loaiza, Díaz de Tuesta del Arco, J.L., Martinez del Prado, P.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
234P Real-world treatment patterns and outcomes of patients receiving palbociclib plus endocrine therapy in Spain: Subgroup analysis based on age, sites and number of metastatic locations, menopausal status and dose received from PALBOSPAIN study
Anton, F. Moreno, Bellet-Ezquerra, M., Sanchez, L.M. Manso, Carrasco, F. Henao, Torres, A. Anton, Morales, S., Ortega, P. Tolosa, Gil, V.L. Obadia, Sampedro, T., Conejero, R. Andrés, Calvo-Martinez, L., Galve-Calvo, E., López, R., Ayala de la Pena, F., Lopez-Tarruella Cobo, S., Hernando Fernandez, B.A., Ruiz, L. Boronat, Cardenas, T. Martos, Chacon, J.I., Jañez, N. Martinez
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
TEMPORARY REMOVAL: PO-14: Real-world data: incidence of venous thromboembolism recurrence and bleeding among cancer patients
Silva-Cardenas, D C, Pikabea-Diaz, F, Zumarraga-Cuesta, A, Lopez-Santillan, M, Figaredo-Berjano, C, Loaiza-Jaramillo, P L, Casado-Cuesta, P, Temiño-Frances, M, Lopez-de-San-Vicente-Hernandez, B, Novo-Sukia, E, Legaspi-Folgueira, J, Barcelo-Galindez, J R, Sande-Sardina, L, Nuno-Escolastico, M, Abad-Villar, M T, Sala-Gonzalez, M A, Galve-Calvo, E, Martinez-Del-Prado, M P
Published in Thrombosis research (01.05.2022)
Get full text
Published in Thrombosis research (01.05.2022)
Journal Article
Prognostic Factors Influencing the Selection of Bevacizumab Combined With Chemotherapy in Patients With HER2-Negative Metastatic Breast Cancer in Routine Clinical Practice. Oncosur-Avalox: Observational Cross-Sectional Study
Manso, L., Perez-Carrion, R., Chacon Lopez-Muniz, J.I., García Palomo, A., Galve Calvo, E., Llorente, R.M., Casinello, J., Catalán, G., Llorca, C., Grávalos, C.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Induction Chemotherapy (Ict) with Docetaxel/Cisplatin/5-Fluorouracil (T/P/F) Followed By Chemoradiotherapy with Cisplatin (Crtp) Vs Bioradiotherapy with Cetuximab (Rtcx) for Unresectable Locally Advanced Head & Neck Cancer (Ulahnc): Preliminary Results on Toxicity a Ttcc Group Trial
Hitt, R., Mesia, R., Grau, J.J., Rubió, J., Martínez-Trufero, J., Del Barco Morillo, E., Almodóvar Alvarez, C., Taberna-Sanz, M., García-Girón, C., Vazquez, S., Cirauqui, B., Pastor Borgoñón, M., Galve Calvo, E., Juan-Vidal, O., Lopez, R., Martinez-Galan, J., Bastus, R., Berrocal, A., Adansa Klain, J.C., Cruz Hernandez, J.J.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
1035PINDUCTION CHEMOTHERAPY (ICT) WITH DOCETAXEL/CISPLATIN/5-FLUOROURACIL (T/P/F) FOLLOWED BY CHEMORADIOTHERAPY WITH CISPLATIN (CRTP) VS BIORADIOTHERAPY WITH CETUXIMAB (RTCX) FOR UNRESECTABLE LOCALLY ADVANCED HEAD & NECK CANCER (ULAHNC): PRELIMINARY RESULTS ON TOXICITY A TTCC GROUP TRIAL
Hitt, R., Mesia, R., Grau, J.J., Rubió, J., Martínez-Trufero, J., Del Barco Morillo, E., Almodóvar Alvarez, C., Taberna-Sanz, M., García-Girón, C., Vazquez, S., Cirauqui, B., Pastor Borgoñón, M., Galve Calvo, E., Juan-Vidal, O., Lopez, R., Martinez-Galan, J., Bastus, R., Berrocal, A., Adansa Klain, J.C., Cruz Hernandez, J.J.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article